Table 12.
% in PBMNC | % in QQMNC | P Value | Ratio | P Value | |
---|---|---|---|---|---|
CD34+ | 0.21±0.03 | 1.25±0.26** | 0.0078 | 5.97±0.88** | 0.0078 |
CD133+ | 0.23±0.08 | 0.48±0.08 | 0.0977 | 3.59±0.71* | 0.0195 |
VEGFR‐2+ | 1.07±0.15 | 0.67±0.28 | 0.2500 | 0.61±0.21 | 0.2500 |
CD31+ | 39.60±1.93 | 40.66±1.89 | 0.2969 | 1.03±0.02 | 0.2969 |
vWF+ | 10.52±3.63 | 10.33±4.07 | 0.7422 | 0.85±0.06* | 0.0391 |
CD105+ | 22.65±1.37 | 32.05±2.84* | 0.0313 | 1.40±0.05* | 0.0313 |
CD146+ | 1.57±0.20 | 2.09±0.16 | 0.1094 | 1.48±0.17 | 0.1094 |
CD3+ | 55.16±4.12 | 71.30±2.61** | 0.0078 | 1.33±0.08** | 0.0078 |
CD4+ | 34.38±4.27 | 46.38±3.28* | 0.0350 | 1.41±0.12* | 0.0313 |
CD8+ | 19.54±2.70 | 22.03±1.80* | 0.0345 | 1.18±0.08* | 0.0313 |
CD16+ | 35.66±1.73 | 31.76±0.88 | 0.2500 | 0.90±0.06 | 0.2500 |
CD19+ | 22.00±2.27 | 6.98±0.16* | 0.0350 | 0.33±0.03* | 0.0313 |
CD56+ | 24.50±1.17 | 7.63±1.11* | 0.0350 | 0.30±0.03* | 0.0313 |
CD14+ | 19.80±1.73 | 3.47±0.57** | 0.0078 | 0.19±0.04** | 0.0078 |
CD11c+ | 35.81±2.19 | 39.57±2.39* | 0.0391 | 1.11±0.03* | 0.0391 |
CCR2+ | 15.70±1.48 | 0.22±0.06* | 0.0350 | 0.01±0.004* | 0.0355 |
CD206+ | 5.53±0.33 | 26.28±2.69* | 0.0350 | 4.95±0.70* | 0.0355 |
CD235a+ | 0.88±0.09 | 0.71±0.03* | 0.0211 | 0.83±0.05* | 0.0223 |
CD3+/CXCR4+/CD31+ | 30.28±1.75 | 41.01±2.07* | 0.0350 | 1.37±0.07* | 0.0350 |
“% in PBMNC” and “% in QQMNC” indicate the % positivity of each cell population in the whole cell of QQMNC and PBMNC. “Ratio” means the ratio of the % positivity in the whole cell of QQMNC to that of PBMNC, corresponding to Figure 2C. The left P values indicate the comparison of % cell positivities between QQMNC and PBMNC; the right ones indicate that of the ratios. N=4 to 6 volunteers. CCR2 indicates CC chemokine receptor 2; CXCR4, C‐X‐C chemokine receptor type 4; PBMNC, peripheral blood mononuclear cell; QQMNC, quality and quantity control culture of mononuclear cell; VEGFR, vascular endothelial growth factor receptor; vWF, von Willebrand factor.
*P<0.05; **P<0.01 versus PBMNC.